From Phase I to Phase II: A Guide to Advancing Your NIH SBIR Research and Development Efforts

August 14, 2025 · 3 min read

Granted Research Team · Editorial policy

Cover image

Introduction to Advancing Your NIH SBIR Research and Development Efforts

The National Institutes of Health (NIH) Small Business Innovation Research (SBIR) program is a highly competitive funding opportunity for small businesses to engage in innovative research and development efforts. As a grant proposal writing instructor, I have seen many applicants struggle with the transition from Phase I to Phase II of the program. In this blog post, I will provide practical advice and best practices to help you successfully advance your NIH SBIR research and development efforts.

Understanding the Difference Between Phase I and Phase II

Before diving into the tips and best practices, it is crucial to understand the difference between Phase I and Phase II of the NIH SBIR program:

Phase I

Phase II

Best Practices for Advancing from Phase I to Phase II

1. Demonstrate Progress and Success in Phase I

To successfully advance to Phase II, it is essential to demonstrate the progress and success of your Phase I research and development efforts. This includes providing evidence of technical feasibility, proof-of-concept, and preliminary data that supports the potential for commercialization.

For example, if your Phase I project focused on developing a novel drug delivery system, you should provide data on the system's effectiveness in delivering the drug, its safety, and any preliminary results from animal studies or clinical trials.

2. Develop a Comprehensive Commercialization Plan

A strong commercialization plan is a key component of a successful Phase II proposal. This plan should include:

3. Assemble a Strong Team and Collaborators

The expertise and experience of your team and collaborators can significantly impact the success of your Phase II proposal. Be sure to:

4. Address Reviewer Feedback from Phase I

Incorporating reviewer feedback from your Phase I proposal can strengthen your Phase II application. Be sure to:

Conclusion

Successfully advancing from Phase I to Phase II of the NIH SBIR program requires a strong understanding of the program's objectives, a demonstration of progress and success in Phase I, and a well-developed commercialization plan. By following these best practices and seeking guidance from experienced grant proposal writing instructors, you can increase your chances of securing funding for your innovative research and development efforts.

Granted's AI coaching is built to help you navigate the Phase I-to-Phase II transition -- from presenting your feasibility data to building the detailed commercialization narrative reviewers expect. Learn how Granted supports SBIR applicants.

Keep Reading


Ready to find and win your next grant? Granted AI searches 85,000+ opportunities, analyzes your RFP, coaches you through each section, and runs AI committee review before you submit. Start free -- no credit card required.

Get AI Grants Delivered Weekly

New funding opportunities, deadline alerts, and grant writing tips every Tuesday.

Browse all SBIR grants

More SBIR Articles

NSF Is Putting $16M Into Six to Eight SBIR Companies. The Pilot Is Also a Study, and That Changes Who Should Apply.

NSF's $20 million Commercialization Readiness Pilot, announced September 14, 2026 and led by UCF's National Commercialization and Translation Institute, will give six to eight Phase II and IIB deep-tech firms milestone awards of $1 million to $3.75 million. Roughly one in ten NSF Phase IIB alumni will get a seat. Here is how the selection logic actually works.

Read article

Two NSF Grandfather Clauses Expire on the Same Day: What November 4, 2026 Does to Companies Stranded by the SBIR Shutdown

NSF's restarted SBIR/STTR program carries two transition rules almost nobody has calendared. Project Pitch invitations issued on or after July 3, 2025 must be converted to a full proposal by November 4, 2026. Phase I awardees whose awards started on or after November 6, 2023 must submit Phase II by the same date. Both cohorts were created by the program lapse, and both cliffs are hard.

Read article

Five of Seven Topics Came From One Office: Inside DARPA's Release 6 SBIR Drop and the $7M Battlefield-Medicine Stack Closing October 21

DARPA pre-released Release 6 of its FY26 SBIR BAA on September 2, 2026. Five of the seven SBIR topics belong to the Biological Technologies Office, and four of those describe one continuous problem: keeping a casualty alive with no surgeon, no imaging, and no evacuation. Here are the award sizes, the Direct-to-Phase-II gates, and the sequencing DARPA is buying.

Read article

Not sure which grants to apply for?

Use our free grant finder to search active federal funding opportunities by agency, eligibility, and deadline.

Find Grants

Ready to write your next grant?

Draft your proposal with Granted AI. Professional members win a grant in 12 months or get a full refund.

Backed by the Granted Guarantee